Skip to content

Biotech joins efforts to aid in humanitarian relief in Ukraine

The biotech industry is coming together to donate a range of critical medical supplies, equipment and medications to the people of Ukraine.

NCBIO Roadmap to Diversity Event

“Our workforces are more dynamic. They're more empowered, they're more enlightened, and they want answers not just from the standpoint of their functional skills and capabilities in our business performance. But also what is it that our company stands for?” -- Keynote speaker Celeste Warren, VP, Merck Global Diversity and Inclusion Center

Bio Business Solutions

NCBIO Members Save Big with BIO Business Solutions

BIO Business Solutions offers NCBIO members the opportunity to pool their purchasing power with other life science companies nationwide to command significant discounts for frequently used products and services.

Bio Business Solutions

NCBIO, the North Carolina Biosciences Organization

NCBIO is the trade association for North Carolina’s life science industry. Members include companies and research institutions working in the pharmaceutical, medical device, diagnostic, clinical research and agricultural biotechnology sectors, as well as firms and nonprofits that provide support services to life science companies. Founded in 1994, NCBIO works to help North Carolina’s life sciences community fulfill its extraordinary promise as a source of economic opportunity and improved quality of life through effective advocacy and policy.

Member Benefits

A variety of discount programs are available to members.

BIO: CMS decision enormous setback for Alzheimer’s patients, dangerous infringement on FDA autonomy

April 8, 2022

On April 7, the Centers for Medicare and Medicaid Services held to its original decision to limit coverage of the…

Read More

Biotech joins efforts to aid in humanitarian relief in Ukraine

March 4, 2022

The biotech and life sciences industry is coming together to donate a range of critical medical supplies, equipment, and medications…

Read More

CMS decision not to cover Alzheimer’s treatment a bad one

March 2, 2022

NCBIO stands in solidarity with patient advocates and industry leaders in opposing the Centers for Medicare and Medicaid Services’ draft…

Read More

Who pays to create new medicines?

January 13, 2022

Does government spending on drug development justify government price controls on medicines? Not when the private sector spends $102 billion on clinical R&D and the NIH spends less than $3 billion.

Read More

2022 Legislative Reception (photo gallery)

June 23, 2022

NCBIO held its 2022 Legislative Reception on Wednesday, June 22, at the North Carolina Museum of History in Raleigh. The event was well attended by NCBIO members who were joined by a number of state senators, including Life Science Caucus Co-Chair Sen. Mike Woodard and Sens. Lisa Barnes, Sydney Batch, Steve Jarvis and Joyce Waddell.

Read More
NCBIO's John Wagner and Merck's Vinay Khanna at the June 1 NCBIO Biomanufacturers Forum

Supply chain during pandemic discussed at June Biomanufacturers Forum meeting 

June 3, 2022

Representatives of Merck and NCBIO discussed the supply-chain difficulties and issues the COVID-19 pandemic created for the bioscience industry at the quarterly NCBIO Biomanufacturers Forum meeting held Wednesday, June 1, at the NC Biotechnology Center.

Read More

Medical Device Forum discusses current FDA regulatory environment 

May 31, 2022

NCBIO members got an overview of the Food and Drug Administration’s regulatory environment for medical devices both during the pandemic and now at the NCBIO Medical Device Forum held May 11 at the NC Biotechnology Center.

Read More
NCBIO President Laura Gunter and Sam Taylor's wife, Nancy Reed, at the opening of Wake Tech’s Lilly Science and Technology Center

Lead gifts from Alexandria Real Estate, Biogen, Hatteras push Taylor scholarship fund past $200,000

April 8, 2022

The Samuel M. Taylor Memorial Scholarship Fund created by NCBIO at the North Carolina Community Colleges Foundation Inc. has exceeded $200,000 in gifts and pledges with leadership gifts coming from Alexandria Real Estate Equities, Biogen and Hatteras Venture Partners.

Read More

Sustaining Members

Pfizer logo

Supporting Members